Invictus RG’s Johnson & Johnson JNJ Stock Holding History

Invictus RG’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-348	Closed	-$40K	–	764
2016 Q4	$40K	Sell	348 -21	-6%	-$2.43K	0.03%	475
2016 Q3	$44K	Buy	+369	New	+$44.8K	0.03%	468

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Invictus RG's JNJ Position: Q1 2017 in Review

Invictus RG sold out of Johnson & Johnson (JNJ) in Q1 2017, closing a stake of 348 shares — an estimated $40K sold.

Invictus RG first reported a position in JNJ in Q3 2016 and held it in 2 quarters. The position peaked at $44K in Q3 2016. 2,349 funds tracked by Wall St. Rank hold JNJ as of Q1 2017.

Invictus RG reported no remaining Johnson & Johnson position as of Q1 2017 after selling out during the quarter.
Invictus RG sold 348 Johnson & Johnson shares in Q1 2017, an estimated $40K.
Invictus RG first reported a position in Johnson & Johnson in Q3 2016 and held it in 2 quarters.
Invictus RG's Johnson & Johnson position peaked at $44K in Q3 2016.
2,349 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2017.

Based on Invictus RG's 13F filing for Q1 2017, filed 12 May 2017.